Neutralizing monoclonal antibodies (MAbs) directed to the VP7 protein and neutralization-resistant mutants were used to analyse the antigenic structure of VP7 of human rotavirus serotype 1. Cross-neutralization tests using the MAbs and the resistant mutants indicated the existence of two functionally independent neutralization epitope regions (S1 and $2) on VP7. Region S1 corresponds to a single epitope domain of VP7 which has been detected previously. Two MAbs prepared in this study recognized the S1 region, and the resistant mutants they selected had amino acid substitutions at positions 94 or 213. On the other hand, region $2 is considered to be a novel epitope. Single or double amino acid substitutions were detected in the variable regions (amino acid positions 145, 217 and 221) and in the constant regions (positions 104, 201 and 291) of the VP7 protein of mutants selected by MAbs directed to the $2 region. It was suggested that the variable region E (amino acids 208 to 221) includes two independent neutralization sites, and that amino acid substitutions in the constant region of VP7 also affect serotype-specific neutralization epitopes. Neutralization epitopes on VP7 are considered to be highly dependent on the conformation of VP7.
Introduction
Since rotavirus has been recognized as an important cause of diarrhoea in infants and children world-wide , the need for the development of vaccines against rotavirus infection has been highlighted. Rotavirus particles consist of an outer and inner capsid and contain 11 segments of genomic RNA. Two major neutralization proteins on the outer capsid, VP4 and VP7, are encoded respectively by RNA segment 4 (Mason et al., 1983; Kalica et al., 1983) and segments 7, 8 or 9 depending on the strain (Greenberg et al., 1983a; Kalica et al., 1981; Ward et al., 1988) . Most of the serotype-specific neutralization epitopes are located on VP7 (Greenberg et al., 1983b Taniguchi et al., 1985) , while common antigens among different serotypes are mainly on VP4 (Mackow et aL, 1988b; Taniguchi et al., 1988b) . Analysis of these neutralization antigens, especially the determination of amino acid positions that are critical for virus neutralization, provides valuable basic information for development of a rotavirus vaccine. Such investigations on VP7 have been performed by the production of neutralizing monoclonal antibodies (MAbs) and the use of mutants resistant to each neutralizing MAb in serotype 3 simian rotavirus strains SA 11 (Dyall-Smith et al., 1986; Lazdins et al., 1985) and rhesus rotavirus (RRV) (Shaw et al., 1986) , serotype 3 human rotavirus (HRV) strain RV-3 0000-9707 © 1991 SGM (Dyall-Smith et al., 1986) , and serotype 1 HRV strain KU Taniguchi et al., 1988a) . These analyses indicated that two variable regions on VP7 (amino acids 87 to 101 and 208 to 221) are mainly involved in virus neutralization, and that they correlate functionally with each other and form a single large antigenic site. However, no further investigation has been made as to the possible existence of other neutralization epitopes and their functional relationship with the known antigenic sites mentioned above. We have extended the antigenic analysis of VP7 of the commonest serotype 1 rotavirus by using newly prepared neutralizing MAbs and mutants in addition to those prepared previously .
Methods
Cells and viruses. Rotaviruses were propagated in MA104 cells, a continuous cell line derived from rhesus monkey foetal kidney (Urasawa et al.. 1981) . The following HRVs were employed: KU, Wa, S12, K8 and M37 (serotype 1); $2, HN126, AK26, DS-1 and 1076 (serotype 2); YO, $3. P2, P, AK35 and McN13 (serotype 3); Hochi, Hosokawa and ST#3 (serotype 4); 69M (serotype 8) and WI61 (serotype 9). Simian rotaviruses SAll and RRV (serotype 3) and bovine rotavirus NCDV (serotype 6) were also used.
Hybridoma production. Purified serotype 1 strain KU or K8 (Urasawa et al., 1984) was injected into adult female BALB/c mice. The immunization schedule and fusion procedure were according to methods described previously (Taniguchi et al., 1985) . We employed the myeloma cell lines P3-X63-Ag8.653 and PAI (Stocker et al., 1982) , the latter of which was provided by the Japanese Cancer Research Resource Bank, The hybridomas producing MAbs were screened by the fluorescent-focus reduction neutralization (FFN) test using KU. For some screenings, antigenic mutants ofKU (V-KU-6A1 I, V-KU-4, V-KU-5HI, V-KU-3C7, V-YO-4C2-1 and V-YO-4C2-II) prepared previously were used to select the neutralizing MAbs directed at novel neutralizing epitopes, since MAbs neutralizing both KU and all the mutants were expected to recognize the epitopes different from those previously detected. The protein specificity of the MAbs was determined by the FFN test using reassortant rotavirus strains C15 (Urasawa et al., 1986) and P x K8-A2 (Kobayashi et al., unpublished results). VP4 and VP7 of C15 were derived from strains Wa (serotype 1) and HN126 (serotype 2), respectively, P x K8-A2 had the VP4 and VP7 proteins derived from serotype 3 strain P and serotype l strain K8, respectively.
FFN test and ELISA. The reactivity of MAbs to rotaviruses was examined in FFN tests and ELISA as described previously . A cross-reactive anti-VP4 MAb (YO-2C2) (Taniguchi et al., 1985) was employed in the ELISA to check the amount of doubleshelled particles of the rotaviruses except strain KS.
Neutralization-resistant mutants and cross-neutralization test.
Resistant mutants of serotype 1 HRV KU were selected by neutralizing MAbs produced in this study through two successive selections and were plaque-purified as described previously Morita et al., 1988) . Some mutants of serotype 1 strain M37 were also selected by two neutralizing MAbs. Cross-neutralization tests between the neutralizing MAbs and the mutants including those previously prepared were performed by FFN tests.
RNA sequencing analysis. The nucleotide sequence of the gene encoding VP7 of the mutants was determined by the dideoxynucleotide chain termination method as described by Gorziglia et al. (1986) . Single-shelled particles of antigenic mutant strains were purified by centrifugation in CsC1 gradients and single-stranded RNA transcripts were prepared as described by Flores et al. (1982) . Dideoxynucleotide sequencing of RNA transcripts was performed following the method described previously (Oorziglia et al., 1986; Green et aL, 1988 ) by using five oligonucleotide primers which were complementary to the VP7 gene sequence at nucleotide positions 228 to 244, 375 to 391,588 to 611, 801 to 819 and 1039 to 1057 of strains RRV, ST#3, NCDV or Wa.
Results

Production of hybridomas and neutralizing MAbs
By two separate fusion procedures, we obtained eight hybridomas producing neutralizing MAbs. Of these, six hybridomas (K8-6D6, K8-3C10, K8-1D15, K8-4C4, K8-3H16 and KS-3H17) secreted MAbs neutralizing strain KU and six KU antigenic mutants prepared previously (V-KU-4, V-KU-5H1, V-KU-3C7, V-KU-6A11, V-YO-4C2-I and V-YO-4C2-II). As shown in Table 1 , all the MAbs specifically neutralized serotype 1 HRV strains except for strain M37 which was neutralized by only two MAbs, K8-3H16 and K8-3H17. In ELISA, the reactivities of these MAbs were also serotype 1-specific, although M37 was reactive with only three MAbs, KU-6BG, K8-3H16 and K8-3H17 (data not shown). The protein specificity of these MAbs was determined to be VP7 because all the MAbs neutralized reassortant P × K8-A2 whereas no reaction with reassortant strain C15 was observed. The reactivities of six previously prepared VP7-specific MAbs were examined against the M37 strain; only KU-2 and KU-4 were reactive with M37 in both neutralization tests and ELISA, while YO-4C2 showed a positive reactivity only in ELISA (data not shown).
Epitope mapping study
Neutralization-resistant mutants were selected successfully from the parent strain KU, using all of the eight MAbs but K8-3H17. A mutant was designated ,¥2 followed by the name of the MAb that was used for its selection. We characterized two mutant clones for each of the MAbs K8-4C4, K8-3C10 and K8-lD15, and designated them by inserting 'I' or 'II' after the name of the mutant. Cross-neutralization tests were performed between the neutralizing MAbs and all the mutants including those prepared previously . The results are shown in Table 2 . A mutant was considered to be resistant to a MAb when the neutralizing titre of the MAb against the mutant decreased to less than ~ of the titre against the parental strain KU. When reciprocal or non-reciprocal interactions were observed between pairs of MAbs and the resistant mutant, the two epitopes recognized by the individual MAbs were considered to overlap each other operationally.
As shown in Table 2 , two operationally distinct neutralization epitope regions (S1 and $2) on the VP7 of strain KU were defined. Epitope region S1 was considered to consist of two epitope subregions, Sla and Slb, which partially overlap each other, because only MAb KU-6A11 lost neutralizing activity with most of the mutants selected by other MAbs recognizing epitope region S1. The cross-reactive anti-VP7 neutralizing MAb YO-4C2 epitope was included in the epitope group S1. The other epitope region, $2, which had no operational relationship with region S1, was recognized by six MAbs (K8-3H16, K8-3H17, K8-1D15, K8-6D6, K8-3C10 and K8-4C4) which had been selected on the basis of their distinct neutralizing activity against the mutants prepared previously. Three different reaction patterns of the mutants against the six MAbs recognizing epitope region $2 were observed: (i) V-K8-3H16 and V-K8-6D6 were resistant to all MAbs recognizing the region $2, (ii) V-K8-3CI0-I, V-K8-1D15-I and V-K8-1D15-II were resistant to all the MAbs except K8-3H16 and K8-3H17, but the neutralizing titres of these two MAbs to V-K8-3C10-I were rather lower than those to other mutants and (iii) V-K8-3C10-II, V-K8-4C4-I and V-K8-4C4-II were resistant to only three MAbs, KS-6D6, K8-3C10 and K8-4C4. That epitope regions S1 and $2 were distinct was confirmed by the production of resistant mutants of strain M37, whose VP7 antigenicity was suggested to be slightly different from that of the other serotype 1 strains because the strain was not neutralized by many serotype 1-specific neutralizing MAbs (Table 1) . Two clones per MAb of neutralization-resistant mutants of M37 were selected by MAbs KU-4 and K8-3H16, which had been found to recognize regions S1 and $2, respectively on the VP7 of KU. Cross-neutralization tests were performed among these mutants and MAbs KU-4, K8-3H16 and K8-3H 17 (Table 3) . Two mutant clones (MV-KU-4-I and MV-KU-4-II) selected by KU-4 were resistant only to KU-4, whereas the other two mutant clones (MV-K8-3H16-I and MV-K8-3H16-II) selected by K8-3H16 were resistant to KS-3H16 and K8-3H17. These results indicated that neutralization epitopes on VP7 of M37 recognized by KU-4, and those recognized by K8-3H16 and K8-3H17 were functionally different. Thus, it was confirmed that two distinct neutralization epitope groups are present on VP7 of serotype 1.
Detection of amino acid substitution sites of the mutants
Two distinct epitope regions were analysed by determining the complete VP7 amino acid sequences of the mutants and comparing them with that of the parent strain KU. Several amino acid substitution sites on VP7 had already been detected in the mutants (V-YO-4C2-I, V-YO-4C2-II, V-KU-5H1, V-KU-6A 11, V-KU-4 and V-KU-3C7) selected by MAbs directed at the region S1 . Two mutants selected by MAbs recognizing region S1, KU-3A and KU-6BG were found to possess amino acid changes at positions 94 and 213, respectively (Table 4) . These sites are consistent with those found in mutants V-KU-3C7 and V-KU-4.
The VP7 genes of eight mutant clones of the newly identified region $2 were sequenced and single or double amino acid changes were detected (Table 4) . Three mutant clones (V-K8-3C10-II, V-K8-4C4-I and V-K8-4C4-II) possessed a single amino acid substitution at position 217, while two mutants V-K8-6D6 and V-K8-3H16 had an amino acid change at position 221. These positions are included in a variable region E (amino acids 208 to 221) and serotype 1 strains possess identical amino acids at both positions. These amino acids are different from those found in the strains of other serotypes (Green et al., 1987 . The other three mutant clones possessed double amino acid changes. V-K8-3C10-I had amino acid substitutions at positions 104 and 145, which were located within the constant region (amino acids 102 to 119) and the variable region (amino acids 143 to 152), Table 2 .
Epitope analysis of antigenic mutants (KU strain) selected with VP7-specific neutralizing MAbs
Neutralizing titre* of MAbs Table 1 . t Neutralizing titre that is less than ~ the titre against the parent strain KU. As for MAbs KU-6A 11, K U-4 and K8-3C10, neutralizing titre to a mutant of less than 1600 was regarded as indicating resistance to the mutant. Two independent mutant clones selected with MAbs YO-4C2, K8-4C4, K8-1D15, and K8-3Cl0 were distinguished by q' or 'II' following the name of the mutant.
Combinations of MAbs recognizing functionally distinct epitope regions (Sla, Slb, $2) and their corresponding resistant mutants are boxed. § NT, Not tested. Epitope region S1 800 800 800 800 < 100 < 100 < 100 < 100 1600 1600 Y $2 * Two independent mutant clones selected with MAbs KU-4 and K8-3H16 were distinguished by T or 'II' following the name of the mutant.
t See footnote * of Table 1 .
:~ See footnote ~ of Table 2. 1988; Urasawa et al., t987, 1989) , and because only a few animal virus strains belonging to this serotype have been found (Bellinzoni et al., 1990) , unlike serotypes 3 and 4 . Amino acid sequence analysis of VP7 revealed at least six variable regions (A to F) that are quite different among the different serotypes but are conserved among the strains of a given serotype. Therefore, some of these variable regions are thought to be involved in serotype specificity (Glass et al., 1985; Green et al., 1987) . In contrast, the remaining parts of the sequence, the constant regions, are thought to be only slightly concerned with serotype specificity. Amino acid substitution sites that have been detected on VP7 of the mutants resistant to individual neutralizing MAbs are located in three variable regions, i.e. B, amino acids 87 to 101 (positions 94, 96, 97 and 99); D, amino acids 143 to 152 (position 147); E or VR-8, amino acids 208 to 221 or 224 (positions 211,213, 221 and 223) (Dyall-Smith et al., 1986; Mackow et al., 1988a; Nishikawa et al., 1989;  
AAA-,AAC (291) Lys~Asn * Amino acid sequences of resistant mutants were compared with that of parent strain KU (Taniguchi et al., 1988a) .
i" Numbers in parentheses show the position of nucleotide substitutions. :~ Numbers in parentheses show the position of amino acid substitutions. § I and II indicate different mutant clones selected with a single MAb.
respectively. In contrast, both amino acid changes (amino acids 201 and 291) of the mutants V-K8-1D15-I and V-K8-1D15-II were located in the constant region.
Discussion
In the present analysis of the HRV VP7 antigen, HRVs of serotype 1 were employed because they have been detected at the highest frequency in most epidemiological studies (Ahmed et al., 1989; Georges-Courbot et al., Taniguchi et al., 1988a) according to the nomenclature described by Glass et al. (1985) and Green et al. (1989) . The B and E regions on VP7 of HRV KU are considered to form a conformational antigenic site in which several epitopes correlate functionally with each other, because it was demonstrated that the mutants with amino acid changes in region B became resistant to the MAb which selected the mutants with amino acid changes in region E, and vice versa Taniguchi et al., 1988a) . A similar result was obtained in the study on VP7 ofSAl 1 (Dyall-Smith et al., 1986) . The epitope region S1
designated in the present study is thought to correspond to the single large epitope region reported previously which consists of at least five different epitopes overlapping operationally. In this study, we revealed the presence of another epitope region (region $2) on VP7 which is independent of region S1. The determination of the amino acid sequences of the VP7 mutants obtained in this study showed that the five mutant clones selected by the MAb recognizing region $2 contained amino acid substitutions at positions 217 or 221. These amino acid positions are located in the same variable region E (208 to 221) including the positions 211 and 213, which had been identified in the mutants selected by the MAbs recognizing region S1, KU-6A11 and KU-4 (Taniguchi et aL, 1988a) as well as KU-6BG prepared in this study. A similar observation was reported in a study using SA11 (Dyall-Smith et al., 1986) . Thus, mutants selected with MAbs recognizing different epitope regions sustained amino acid substitutions in positions close to each other. In contrast, our previous study Taniguchi et al., 1988a) indicated that, in the mutants selected with some MAbs directed to the same epitope region, the amino acid changes were found at widely spaced positions. These findings imply that VP7 neutralization epitopes are highly conformational. We obtained the mutant V-K8-3C10-I which had amino acid changes at positions 104 and 145. The latter position is located in the variable region D (amino acids 143 to 152). Although region D has been thought to be independent of the variable regions B and E, the results of the present study suggest that the variable regions B, D and E are functionally related to one other.
One mutant clone V-K8-3C10-I and two further mutant clones V-K8-1D 15-1 and V-K8-1D 15-I1 selected with each of the two neutralizing MAbs recognizing epitope group $2 had double amino acid changes at positions 104 and 145, and 201 and 291, respectively. These results were surprising because the three amino acid positions (104, 201, and 291) are located in constant regions. On the basis of the present knowledge of the molecular structure of rotaviruses, it is difficult to explain, especially for the mutant clones V-K8-1D15-I and V-K8-ID15-II, the relationship between the occurrence of two amino acid changes in the constant regions and the development of resistance to serotype 1-specific neutralizing MAbs. It is possible that the positions where the mutants underwent changes are not the actual binding sites of the MAbs. Double mutations in viral proteins of mutants selected by a single MAb have been detected in studies on several viruses (Baxt et al., 1989; Caton et al., 1982; Coelingh et al., 1989; Lobigs et al., 1987; Page et al., 1988; Underwood et al., 1987; Vandepol et al., 1986) . In a study on the antigenic structure of influenza virus haemagglutinin, it has been inferred, on the basis of analysis of the three-dimensional structure of the antigen (Caton et al., 1982; Gerhard et al., 1981) , that out of the two amino acid changes found in the resistant mutant, only one might be involved in antibody recognition. Whether this is also the case for the double amino acid changes found for rotavirus in this study cannot be decided until the precise conformational structure of VP7 has been determined.
In this study, strain M37 was neutralized by only a few MAbs although it has been classified as serotype 1 on the basis of serological criteria . Sequence analysis has also revealed that M37 carries several amino acids that are different from those of other serotype 1 HRVs in variable regions B, D and E (positions 94, 97, 147, 208 and 218; Green et al., 1987) , which may be the reason for the failure of many MAbs to neutralize. In serotype 1, 2, 3 and 4 strains, the presence of monotypes which can be differentiated by certain neutralizing MAbs has been identified (Coulson, 1987; Coulson et al., 1985; Gerna et al., 1988; Taniguchi et al., 1985) . The result obtained in the present study indicates that strain M37 may belong to a monotype of serotype 1 rotavirus .
